BTK and PI3K Inhibitors in Development for Chronic Lymphocytic Leukemia
Published: | Updated:
Mark Weiss, MD, from the Kimmel Cancer Center at Jefferson, gives an overview of agents in development for chronic lymphocytic leukemia.
Mark Weiss, MD
Articles by Mark Weiss, MD
Latest Updated Articles
BTK and PI3K Inhibitors in Development for Chronic Lymphocytic LeukemiaPublished: October 18th 2013 | Updated: April 18th 2020